SJÖGREN
Clinical trials for SJÖGREN explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN trials appear
Sign up with your email to follow new studies for SJÖGREN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for Sjogren's disease enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug, CLN-978, given as a shot under the skin for people with active, moderate to severe Sjogren's disease. The main goal is to check safety and side effects, and it will also measure how the drug works in the body and affects immune cells. Abou…
Matched conditions: SJÖGREN
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Massive leukodystrophy biobank aims to unlock disease secrets
Knowledge-focused Recruiting nowThis study collects medical information and biological samples from up to 12,000 people with leukodystrophies—rare brain disorders affecting white matter. Researchers will use this data to find new genetic causes, develop biomarkers, and better understand how these diseases progr…
Matched conditions: SJÖGREN
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC